{"title":"Evaluating AI Competence in Specialized Medicine: Comparative Analysis of ChatGPT and Neurologists in a Neurology Specialist Examination in Spain.","authors":"Pablo Ros-Arlanzón, Angel Perez-Sempere","doi":"10.2196/56762","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>With the rapid advancement of artificial intelligence (AI) in various fields, evaluating its application in specialized medical contexts becomes crucial. ChatGPT, a large language model developed by OpenAI, has shown potential in diverse applications, including medicine.</p><p><strong>Objective: </strong>This study aims to compare the performance of ChatGPT with that of attending neurologists in a real neurology specialist examination conducted in the Valencian Community, Spain, assessing the AI's capabilities and limitations in medical knowledge.</p><p><strong>Methods: </strong>We conducted a comparative analysis using the 2022 neurology specialist examination results from 120 neurologists and responses generated by ChatGPT versions 3.5 and 4. The examination consisted of 80 multiple-choice questions, with a focus on clinical neurology and health legislation. Questions were classified according to Bloom's Taxonomy. Statistical analysis of performance, including the κ coefficient for response consistency, was performed.</p><p><strong>Results: </strong>Human participants exhibited a median score of 5.91 (IQR: 4.93-6.76), with 32 neurologists failing to pass. ChatGPT-3.5 ranked 116th out of 122, answering 54.5% of questions correctly (score 3.94). ChatGPT-4 showed marked improvement, ranking 17th with 81.8% of correct answers (score 7.57), surpassing several human specialists. No significant variations were observed in the performance on lower-order questions versus higher-order questions. Additionally, ChatGPT-4 demonstrated increased interrater reliability, as reflected by a higher κ coefficient of 0.73, compared to ChatGPT-3.5's coefficient of 0.69.</p><p><strong>Conclusions: </strong>This study underscores the evolving capabilities of AI in medical knowledge assessment, particularly in specialized fields. ChatGPT-4's performance, outperforming the median score of human participants in a rigorous neurology examination, represents a significant milestone in AI development, suggesting its potential as an effective tool in specialized medical education and assessment.</p>","PeriodicalId":36236,"journal":{"name":"JMIR Medical Education","volume":"10 ","pages":"e56762"},"PeriodicalIF":3.2000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11611784/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Medical Education","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/56762","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: With the rapid advancement of artificial intelligence (AI) in various fields, evaluating its application in specialized medical contexts becomes crucial. ChatGPT, a large language model developed by OpenAI, has shown potential in diverse applications, including medicine.
Objective: This study aims to compare the performance of ChatGPT with that of attending neurologists in a real neurology specialist examination conducted in the Valencian Community, Spain, assessing the AI's capabilities and limitations in medical knowledge.
Methods: We conducted a comparative analysis using the 2022 neurology specialist examination results from 120 neurologists and responses generated by ChatGPT versions 3.5 and 4. The examination consisted of 80 multiple-choice questions, with a focus on clinical neurology and health legislation. Questions were classified according to Bloom's Taxonomy. Statistical analysis of performance, including the κ coefficient for response consistency, was performed.
Results: Human participants exhibited a median score of 5.91 (IQR: 4.93-6.76), with 32 neurologists failing to pass. ChatGPT-3.5 ranked 116th out of 122, answering 54.5% of questions correctly (score 3.94). ChatGPT-4 showed marked improvement, ranking 17th with 81.8% of correct answers (score 7.57), surpassing several human specialists. No significant variations were observed in the performance on lower-order questions versus higher-order questions. Additionally, ChatGPT-4 demonstrated increased interrater reliability, as reflected by a higher κ coefficient of 0.73, compared to ChatGPT-3.5's coefficient of 0.69.
Conclusions: This study underscores the evolving capabilities of AI in medical knowledge assessment, particularly in specialized fields. ChatGPT-4's performance, outperforming the median score of human participants in a rigorous neurology examination, represents a significant milestone in AI development, suggesting its potential as an effective tool in specialized medical education and assessment.